Acute Coronary Syndrome Flashcards

1
Q

What is acute coronary syndrome (ACS)?

A

Range of conditions related to sudden, reduced blood flow to the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What conditions are under ACS?

A

Unstable angina
NSTEMI
STEMI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does the TIMI score stand for?

A

Thrombolysis in Myocardial Infarction

Predicts the risk of both death and early recurrent ischemic events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What conditions can TIMI risk score be applied to?

A

Unstable angina
NSTEMI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What clinical features are in the TIMI risk score?

A

> 65 years of age
≥3 cardiac risk factors (high cholesterol, hypertension, diabetes, smoker, family history of CAD)
≥50% coronary artery stenosis
Any ASA use within the past 7 days
≥2 episodes of angina within the past 24h
Elevation in cardiac markers (troponin or creatine kinase-myocardial band)
ST segment deviation ≥0.5 mm on ECG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

If patient has UA/NSTEMI and are considered high risk, we would take the __________ strategy route.

A

Invasive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the invasive strategy for UA/NSTEMI?

A

Urgent coronary angiography followed by PCI or bypass if possible

Continuous ECG monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When are patients considered high risk?

A

Positive cardiac enzymes
ST segment changes
TIMI risk score ≥3
Recurrent ischemic symptoms
Heart failure
Hemodynamic instability
Sustained ventricular tachycardia
Prior CABG or PCI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When is a non-pharm for UA/NSTEMI?

A

Bed rest while ischemia is ongoing. Gradually mobilize when symptoms stabilize.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

If patient has UA/NSTEMI, what’s the first thing we want to do?

A

Symptom relief

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do we provide symptom relief for patients with UA/NSTEMI?

A

Nitroglycerin sublingual tablets
Nitroglycerin spray

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When do we consider nitroglycerin IV?

A

If symptoms are not relieved promptly (within 15-20 minutes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Once patient has been stabilized and is symptom-free, what can we use to prevent recurrent episodes of ischemia?

A

Topical nitrates like nitrate patches

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is contraindicated interaction with nitrates?

A

Sildenafil or vardenafil in the previous 24 hours

Tadalafil in the previous 48 hours

Significant hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What therapeutic agents are started for patients with UA/NSTEMI?

A

Beta blockers or CCB
ACEi
Antiplatelet therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When should beta blockers be started for UA/NSTEMI?
Is beta blocker therapy lifetime for UA/NSTEMI?

A

Start as soon as possible

Not lifetime.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

We would typically administer beta blockers orally. When would we administer it IV?

A

If anginal pain is ongoing, administer IV. Then transition to oral once pain is controlled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

When are beta blockers contraindicated?

A
  • Reactive airway disease
  • Bradycardia (HR≤50 bpm)
  • Second or third degree heart block without pacemaker
  • Hypotension (SBP<100)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What do we do if beta blockers are contraindicated?

A

Calcium channel blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

When else do we use calcium channel blockers?

A

When beta blockers are inadequate at optimal doses, we add on CCB
OR
if patient has variant angina (coronary spasm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What calcium channel blockers are preferred if used?

A

DHP CCB (amlodipine)

Avoid NDHP CCB with beta blockers (diltiazem and verapamil) to avoid LV dysfunction and severe bradycardia

Avoid immediate release nifedipine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

When should ACEi be started?
Are they to be continued for lifetime?

A

Within 24 hours of presentation

Lifetime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When is anticoagulation therapy used in UA or NSTEMI?

A

In all patients with UA or NSTEMI and it will be administered again if high risk patient fail PCI/CABG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

When does PCI/CABG come into play for UA/NSTEMI?

A

If they are considered high risk patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Recap: What are clinical factors that make the patient high risk?

A
  • Positive cardiac enzymes
  • ST segment changes
  • TIMI risk score ≥3
  • Recurrent ischemic symptoms
  • Heart failure
  • Hemodynamic instability
  • Sustained ventricular tachycardia
  • Prior CABG or PCI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How do we pick between LMWH and UFH?

A

LMWH is easier to administer, predictable response and no need to monitor.
However, LMWH can’t be used if CrCl is <30 mL/min

UFH would require monitoring.
However, UFH can be used if CrCl<30ml/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

How long do we use heparin therapy for?

A

2-5 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

If we choose to use LMWH, what is the preferred drug?

A

Enoxaparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

When do we use fondaparinux as anticoagulation therapy?

A

Lower incidence of major bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

When do we initiate ASA?
Is therapy for lifetime?

A

ASAP
Continued lifetime

31
Q

When do we use thienopyridines?
Is it for lifetime?

A

They are started with ASA

Continue for 1 year

32
Q

What are the three thienopyridines we can use?

A

Clopidogrel
Prasugrel
Ticagrelor

33
Q

How do we pick between clopidogrel, prasugrel, and ticagrelor?

A

Ticagrelor
- First line (more potent and faster onset)
- If dyspnea, switch to clopidogrel

Clopidogrel
- Second line
- If patient has CYP2C19 gene mutation, patient will have diminished effect -> switch to prasugrel

Prasugrel
- Increase risk of bleeds, especially in those older than 75 years of age, body weight <60kg, and those with history of stroke or TIA
- Good for those undergoing stent implantation or are at higher risk for stent thrombosis

34
Q

If patient is going for non-urgent bypass surgery, how long should we hold ticagrelor for?

35
Q

If patient is going for non-urgent bypass surgery, how long should we hold clopidogrel for?

36
Q

If patient is going for non-urgent bypass surgery, how long should we hold prasugrel for?

37
Q

What is a STEMI?

A

ST segment elevated myocardial infarction

Medical emergency

38
Q

What are non-pharm that are required for STEMI?

A

Bed rest with supplemental oxygen
Continuous ECB monitoring
Gradual mobilization after stabilization

39
Q

What is the first line therapy for STEMI?

A

Urgent coronary angiography with PCI
- Preferred in patients >75 or those with cardiogenic shock

40
Q

When does PCI have to be administered by?

A

Within 2 hours

41
Q

If patient is unable to receive PCI within 2 hours, what do we do?

A

Administer a thrombolytic therapy followed by immediate transfer to a cardiac catheterization centre

42
Q

If administering thrombolytic, what are the therapies of choice?

A

Alteplase
Tenecteplase

43
Q

When is thrombolytic therapy most effective? When does its beneficial effects diminish?

A

Within 6 hours of symptoms onset

Benefit is much less clear after 12 hours

44
Q

Heparins are always used in NSTEMI patients, but are they always used in STEMI patients?

A

If patient got PCI, use of heparin is dependent on the physician

If patient got fibrinolytic therapy, always give UFH

45
Q

Is there a preference for a specific type of heparin?

A

If patient used Tenecteplase, we should use enoxaparin

46
Q

How long should heparin be used in STEMI patients?

A

For a minimum of 48 hours

47
Q

What pharmacotherapy should be started for STEMI patients?

A

ASA
Beta blockers
ACEi/ARBs
Clopidogrel

48
Q

When should ASA be started? Is it for lifetime?

A

ASAP
For lifetime

49
Q

If patient has a history of GI bleeding, what should they take ASA with?

A

PPI to protect the stomach

50
Q

When are beta blockers started for STEMI patients?
Is it for lifetime?

A

Start once hemodynamically stable
Lifetime

51
Q

When should we hold off on starting beta blockers?

A

If patient is bradycardic (HR<50)

52
Q

What is a drug class that we want to avoid in patients with STEMI?

Is there an exception?

A

Calcium channel blockers increase morbidity and mortality rates in patients with STEMI

Can use cautiously if beta blockers are contraindicated or to relieve ischemia/rate control

53
Q

If we are using calcium channel blockers, what is the drug of choice?

A

Diltiazem 90-120 mg daily in divided doses

54
Q

Nitrates are routinely used in NSTEMI.
Are they routinely used in STEMI?

A

Only if ischemia is present or recurrent or if patient had large anterior MI, hypertension or heart failure

55
Q

When do we start ACEi?
Is it for lifetime?

A

Within 24 hours of STEMI
Yes

56
Q

When do we delay the start of the ACEi?

A

If patient is hypotensive (SBP<100 mmHg)

57
Q

When do we use MRA?

A

If they have clinical evidence of heart failure (LV ejection fraction <40% or both)

58
Q

What antiplatelet therapy is used in STEMI patients?

A

Clopidogrel is started with ASA
-Therapy is started with patient is treated with fibrinolysis

59
Q

What are complications of STEMI?

A

Recurrent or ongoing ischemia
Heart failure
Arrhythmias
Pericarditis

60
Q

How do we treat recurrent ischemia?

A

Urgent coronary angiography and revascularization

61
Q

How do we treat heart failure following STEMI?

A

Aggressively as you would with general heart failure

62
Q

If the arrhythmias is an asymptomatic premature ventricular contraction, how do we treat?

A

No treatment needed

63
Q

If arrhythmia is a symptomatic ectopy, how do we treat?

A

Beta blocker
Avoid class IC agent, as they are contraindicated

64
Q

If patient has a.fib, how do we treat?

A

Control ventricular rate (with a beta blocker or digoxin) and consider oral anticoagulant therapy

65
Q

Pericarditis is uncommon following STEMI, but if it occurs, how do we treat?

A

Increase dose of ASA to 650mg QID for 1-2 weeks.
Add-on colchicine if needed

66
Q

If patient has ACS and is pregnant, which therapies are safe? Which pharmacotherapy should be avoided?

A

Safe:
Primary PCI is treatment of choice
ASA
Clopidogrel
UFH and LMWH
Beta blockers
Nitrates

Avoid:
ACEi, ARBs, statins

67
Q

What agent should be started in all ACS patients?

68
Q

If patient has ACS and is breastfeeding, how do we manage? What agents are safe in breastfeeding?

A

Safe:
ASA
UFH
LMWH
Beta blockers

Discontinuation of breastfeeding is preferred for optimal maternal outcomes

69
Q

What is the door to needle time for thrombolytic treatment?

A

30 minutes or less

70
Q

What is the first medical contact to device time for primary PCI?

A

90 minutes or less

71
Q

What are some other add-on agents that can benefit patient care?

A

Stool softeners
-minimizes straining during post MI period

Anxiolytics
- PRN during post MI period

72
Q

What drug therapy should all patients with ACS be started on to decrease cardiovascular risk?

73
Q

What the cholesterol target for those who have had a myocardial infarction?

A

LDL<1.8 mmol/L

74
Q

Does clopidogrel need to be renally adjusted?